“…Bone scintigraphy is a radionuclide technique, using a technetium 99‐phosphorus compound, which is incorporated into bone areas of increased mineralisation. Owing to the excessive bone resorption/lack of osteoblastic activity that characterises the lytic lesions of myeloma, bone scintigraphy has lower sensitivity than conventional radiographs in the detection of osteolytic lesions in myeloma (Bataille et al , 1982; Ludwig et al , 1982; Nilsson‐Ehle et al , 1982; Tamir et al , 1983). However, bone scintigraphy may be helpful in evaluating areas of the skeleton that are not well demonstrated on plain radiography, such as the ribs and sternum (Ludwig et al , 1982; Nilsson‐Ehle et al , 1982; Otsuka et al , 1993).…”